Monday 8 September 2008

Brain Cancer Patients Treated Using Fast And Efficient RapidArc Radiotherapy Technology From Varian Medical Systems

�Two starring cancer centers have carried out groundbreaking radiosurgery treatments for multiple brain metastases using unexampled RapidArc irradiation technology from Varian Medical Systems (NYSE:VAR). The MIMA Cancer Center in Melbourne, Florida and VU University Medical Center in Amsterdam, Netherlands were each able to treat brain metastases more speedily and expeditiously than would have previously been possible.


Stereotactic radiosurgery is used to quick eradicate tumors by targeting them with high doses of radiation using precisely-shaped, image-guided, X-ray beams in just one to basketball team treatment roger Huntington Sessions. Varian's RapidArc, which targets treatment beams at tumors while rotating continuously around the patient, makes it possible to complete stereotactic radiosurgery sessions many times faster than conventional techniques that use stationary beams.


At VU University Medical Center in Amsterdam, doctors used a RapidArc-equipped linear accelerator from Varian to treat